Medicare Enrolled
Dr. Christopher Tsai, MD
Urology Physician · Upland, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tsai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tsai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tsai
Dr. Christopher Tsai is an urology physician in Upland, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tsai performed 3,209 Medicare services across 2,037 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tsai received a total of $5,272 from 54 pharmaceutical and/or device companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tsai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 26% volume in CA
$5,272 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,209
Medicare services
Top 26% in CA for urology physician
2,037
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~160 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,391 | $97 | $330 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
501 | $3 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
424 | $68 | $220 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 174 | $136 | $600 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
168 | $126 | $500 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
120 | $9 | $70 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
114 | $197 | $725 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
74 | $64 | $220 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
61 | $28 | $125 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
35 | $104 | $415 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
23 | $49 | $270 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
17 | $184 | $795 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $116 | $330 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $49 | $205 |
| Injection, garamycin, gentamicin, up to 80 mg | 17 | $2 | $15 |
| Complicated insertion of bladder tube | 16 | $121 | $480 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $131 | $440 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
14 | $20 | $430 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $588 | $2,815 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,272
Total received (2018-2024)
Avg $753/year across 7 years
Top 32% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
253
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,786 (90.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$486 (9.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$891
2023
$1,216
2022
$834
2021
$690
2020
$475
2019
$557
2018
$609
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$191
Sumitomo Pharma America, Inc.
$73
UROGEN PHARMA, INC.
$70
Telix Pharmaceuticals
$66
Bayer Healthcare Pharmaceuticals Inc.
$54
Merck Sharp & Dohme LLC
$51
Janssen Biotech, Inc.
$46
COLOPLAST CORP
$44
Medtronic, Inc.
$42
MIMEDX Group, Inc.
$32
Endo USA, Inc.
$28
Astellas Pharma US Inc
$28
PFIZER INC.
$28
PROCEPT BioRobotics Corporation
$27
ABC Home Medical Supply, Inc.
$24
Dendreon Pharmaceuticals LLC
$21
Axonics, Inc.
$19
180 Medical, Inc.
$19
Antares Pharma, Inc.
$14
Teleflex LLC
$14
Top 3 companies account for 37.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$672
Janssen Biotech, Inc.
$448
PFIZER INC.
$348
Endo Pharmaceuticals Inc.
$287
ABBVIE INC.
$240
AbbVie, Inc.
$231
Teleflex LLC
$217
Myriad Genetic Laboratories, Inc.
$176
Sumitomo Pharma America, Inc.
$168
Axonics, Inc.
$164
AbbVie Inc.
$164
Bayer HealthCare Pharmaceuticals Inc.
$150
UroGen Pharma, Inc.
$150
Myovant Sciences Inc.
$142
Laborie Medical Technologies Corp.
$138
Bayer Healthcare Pharmaceuticals Inc.
$134
Coloplast Corp
$115
UROGEN PHARMA, INC.
$98
COLOPLAST CORP
$87
Medtronic USA, Inc.
$82
Merck Sharp & Dohme LLC
$67
Telix Pharmaceuticals
$66
Medtronic, Inc.
$59
Antares Pharma, Inc.
$55
ABC Home Medical Supply, Inc.
$49
Avadel Specialty Pharmaceuticals, LLC
$46
Hollister Incorporated
$46
Boston Scientific Corporation
$46
Acerus Pharmaceuticals Corporation
$42
Allergan Inc.
$41
C. R. Bard, Inc. & Subsidiaries
$37
Rochester Medical Corporation
$37
MIMEDX Group, Inc.
$32
TOLMAR Pharmaceuticals, Inc.
$31
Amgen Inc.
$30
Cook Medical LLC
$30
Endo USA, Inc.
$28
KARL STORZ Endoscopy-America
$28
PROCEPT BioRobotics Corporation
$27
UROVANT SCIENCES INC
$23
AstraZeneca Pharmaceuticals LP
$21
Dendreon Pharmaceuticals LLC
$21
Blue Earth Diagnostics Limited
$21
AKRIMAX PHARMACEUTICALS, LLC
$20
Travere Therapeutics, Inc.
$20
Amniox Medical, Inc.
$19
180 Medical, Inc.
$19
Supernus Pharmaceuticals, Inc.
$16
Ferring Pharmaceuticals Inc.
$16
Kowa Pharmaceuticals America, Inc.
$15
Photocure Inc
$15
NeoTract Inc.
$15
TISSUETECH, INC.
$14
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 27.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ALTIS · AMS · AQUABEAM SYSTEM · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bulkamid · Cook Medical Dilation/Access · Cook Medical Stents · Cysview · ELIGARD · ERLEADA · Erleada · FEMALE INCONTINENCE · Flex-X · GEMTESA · GENERAL PAIN MANAGEMENT · GREENLIGHT · ILLUCCIX · INTERSTIM · Infyna Chic · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LYRICA · Luja Coude · Lupron · Lupron Depot · MYRISK · Myrbetriq · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Onli · PROLARIS · PROVENGE · Porges Coloplast · SPEEDICATH · Seglentis · SpeediCath · Stendra · TLANDO · TOVIAZ · UROLIFT · UroLift · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
146
Per 100K population
6.7
County median income
$82,184
Nearest hospital
SAN ANTONIO REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tsai is a clinical cardiology specialist, with above-average Medicare volume (top 26% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tsai experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tsai performed 1,391 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tsai receive payments from pharmaceutical companies?
Yes. Dr. Tsai received a total of $5,272 from 54 companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tsai's costs compare to other urology physicians in Upland?
Dr. Tsai's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tsai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Upland
Browse urology physicians in Upland ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology